Their automated venipuncture device has a 98% accuracy rate, reducing patient discomfort and clinical facility costs. VascuLogic is also developing microfluidic assay platforms for use in point of care diagnostic applications, working with their venous access devices. Their mission is to establish their products as the preeminent technological substitute for human intervention in difficult venous access patients, pioneering and dominating a newly emerging clinical market segment of robotics-assisted venous access with their disruptive technology, VenousProTM.